Hematopoietic Precursor Cell Production via iPSC Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The limited supply of genetically-compatible donor blood for clinical and laboratory applications restricts the availability of hematopoietic stem cells and blood cells, necessitating the development of alternative sources for therapeutic and research purposes.
Innovation Solution
A method for producing hematopoietic stem cells from inducible pluripotent stem cells (iPSCs) through a specific differentiation protocol involving various growth factors and culture conditions, including hypoxic and non-hypoxic conditions, to generate hematopoietic precursor cells capable of differentiating into different hematopoietic lineage cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If hematopoietic stem cells are obtained from living donors, then the cells can be used for therapeutic applications, but the limited supply of genetically-compatible donor blood restricts availability
Solution Approach 1:
The invention creates patient-specific induced pluripotent stem cells (iPSCs) by reprogramming the patient's own somatic cells, effectively copying the patient's genetic material to generate hematopoietic stem cells. This eliminates the need for genetically-compatible donors while providing an unlimited supply of autologous cells for therapeutic applications
2Quantity of substance
If a differentiation protocol is developed to generate definitive HSCs from hPSCs, then patient-specific cells can be produced, but the complexity of the differentiation process increases
Solution Approach 1:
The differentiation protocol is divided into distinct sequential phases: mesoderm induction phase, hemogenic endothelium formation phase, and definitive hematopoiesis phase. Each phase uses specific growth factors and culture conditions to guide cells through predetermined developmental stages, making the complex process more controllable and reproducible
Solution Approach 2:
The protocol performs preliminary actions by pre-specifying the sequence of developmental stages and growth factor combinations needed to guide hPSCs through mesoderm formation, hemogenic endothelium differentiation, and eventual HSC generation. This predetermined pathway simplifies the overall process by eliminating trial-and-error approaches
Data Source
AI summary
This invention provides improved methods for generation of hematopoietic precursor cells from a pluripotent stem cell and hematopoietic precursor cells generated thereof. The hematopoietic precursor cells express CXCR4 or runx1c and are capable of homing and/or engraftment in bone marrow.